Results 171 to 180 of about 33,585,029 (332)

Post-treatment life-trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis. [PDF]

Br J Health Psychol
Vojt G, Elliott L, Family H, Sharkey C, Stephens B, Hutchinson S, Hickman M, Dillon JF, Harris M, Flowers P.   +9 more
europepmc   +1 more source

Treatment of histologically benign papilloma of the urinary bladder by local excision and fulguration [PDF]

, 1956
Jennifer A. Nichols, Victor F. Marshall
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Exploring the Effects of Artemisia absinthium L. Essential Oil on Pseudopregnancy Model in Rats. [PDF]

Vet Med Sci
Demirel MA, Süntar İ, Çeribaşı AO, Taban K, Zengin G.   +4 more
europepmc   +1 more source

Some Problems in the Treatment of Puerperal Septic Diseases. [PDF]

, 1908
A. Knyvett Gordon
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

Evaluation of intensity-modulated radiation therapy factors by treatment site and technique for various linear accelerators. [PDF]

J Appl Clin Med Phys
Jegal J, Park MJ, Jung SH, Cho S, Kwak J, Kim JI, Choi CH.   +6 more
europepmc   +1 more source

Notes on the Treatment of Skin Diseases [PDF]

, 1879
Robert Liveling
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

The Treatment of Behavior Disorders Following Encephalitis: An Experiment in Re-Education

, 1932
Léonard Carmichael, EARL D. BOND, Kenneth E. Appel   +2 more
openalex   +2 more sources